カテゴリー： Market Monitor Global, 世界, 医療/バイオ

脳腫瘍診断&治療の世界市場見通し2023年-2029年

◆英語タイトル：Brain Tumor Diagnostics and Therapeutics Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5147）

◆商品コード：MMG23JU5147
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：66
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療機器＆消耗品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Brain Tumor Diagnostics and Therapeutics Market 調査レポートは次の情報を含め、グローバルにおけるの脳腫瘍診断&治療市場規模と予測を収録しています。・世界の脳腫瘍診断&治療市場：売上、2018年-2023年、2024年-2029年
・世界の脳腫瘍診断&治療市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の脳腫瘍診断&治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「手術」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

脳腫瘍診断&治療のグローバル主要企業は、Pfizer、 Novartis、 Roche、 Merck、 Curtana Pharmaceuticals、 GE Healthcare、 Hitachi Medical、 Philips Healthcare、 Novocure、 AbbVie、 Daiichi Sankyo、 Genetech、 Carthera、 EMulate Therapeuticsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、脳腫瘍診断&治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の脳腫瘍診断&治療市場：タイプ別、2018年-2023年、2024年-2029年
世界の脳腫瘍診断&治療市場：タイプ別市場シェア、2022年
・手術、放射線療法、標的療法、化学療法、その他

世界の脳腫瘍診断&治療市場：用途別、2018年-2023年、2024年-2029年
世界の脳腫瘍診断&治療市場：用途別市場シェア、2022年
・病院&がんセンター、腫瘍治療センター、その他

世界の脳腫瘍診断&治療市場：地域・国別、2018年-2023年、2024年-2029年
世界の脳腫瘍診断&治療市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における脳腫瘍診断&治療のグローバル売上、2018年-2023年
・主要企業における脳腫瘍診断&治療のグローバル売上シェア、2022年
・主要企業における脳腫瘍診断&治療のグローバル販売量、2018年-2023年
・主要企業における脳腫瘍診断&治療のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Pfizer、 Novartis、 Roche、 Merck、 Curtana Pharmaceuticals、 GE Healthcare、 Hitachi Medical、 Philips Healthcare、 Novocure、 AbbVie、 Daiichi Sankyo、 Genetech、 Carthera、 EMulate Therapeutics

*************************************************************

・調査・分析レポートの概要
脳腫瘍診断&治療市場の定義
市場セグメント
世界の脳腫瘍診断&治療市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の脳腫瘍診断&治療市場規模
世界の脳腫瘍診断&治療市場規模：2022年 VS 2029年
世界の脳腫瘍診断&治療市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの脳腫瘍診断&治療の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の脳腫瘍診断&治療製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：手術、放射線療法、標的療法、化学療法、その他
脳腫瘍診断&治療のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院&がんセンター、腫瘍治療センター、その他
脳腫瘍診断&治療の用途別グローバル売上・予測

・地域別市場分析
地域別脳腫瘍診断&治療市場規模 2022年と2029年
地域別脳腫瘍診断&治療売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Pfizer、 Novartis、 Roche、 Merck、 Curtana Pharmaceuticals、 GE Healthcare、 Hitachi Medical、 Philips Healthcare、 Novocure、 AbbVie、 Daiichi Sankyo、 Genetech、 Carthera、 EMulate Therapeutics
...

This report aims to provide a comprehensive presentation of the global market for Brain Tumor Diagnostics and Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brain Tumor Diagnostics and Therapeutics. This report contains market size and forecasts of Brain Tumor Diagnostics and Therapeutics in global, including the following market information:
Global Brain Tumor Diagnostics and Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Brain Tumor Diagnostics and Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Surgery Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Brain Tumor Diagnostics and Therapeutics include Pfizer, Novartis, Roche, Merck, Curtana Pharmaceuticals, GE Healthcare, Hitachi Medical, Philips Healthcare and Novocure, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Brain Tumor Diagnostics and Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Brain Tumor Diagnostics and Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Brain Tumor Diagnostics and Therapeutics Market Segment Percentages, by Type, 2022 (%)
Surgery
Radiation Therapy
Targeted Therapy
Chemotherapy
Others
Global Brain Tumor Diagnostics and Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Brain Tumor Diagnostics and Therapeutics Market Segment Percentages, by Application, 2022 (%)
Hospitals and Cancer Center
Oncology Treatment Centers
Others
Global Brain Tumor Diagnostics and Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Brain Tumor Diagnostics and Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Brain Tumor Diagnostics and Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Brain Tumor Diagnostics and Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Novartis
Roche
Merck
Curtana Pharmaceuticals
GE Healthcare
Hitachi Medical
Philips Healthcare
Novocure
AbbVie
Daiichi Sankyo
Genetech
Carthera
EMulate Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Brain Tumor Diagnostics and Therapeutics, market overview.
Chapter 2: Global Brain Tumor Diagnostics and Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Brain Tumor Diagnostics and Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Brain Tumor Diagnostics and Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Brain Tumor Diagnostics and Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Brain Tumor Diagnostics and Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Brain Tumor Diagnostics and Therapeutics Overall Market Size
2.1 Global Brain Tumor Diagnostics and Therapeutics Market Size: 2022 VS 2029
2.2 Global Brain Tumor Diagnostics and Therapeutics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Brain Tumor Diagnostics and Therapeutics Players in Global Market
3.2 Top Global Brain Tumor Diagnostics and Therapeutics Companies Ranked by Revenue
3.3 Global Brain Tumor Diagnostics and Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Brain Tumor Diagnostics and Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Brain Tumor Diagnostics and Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Brain Tumor Diagnostics and Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Brain Tumor Diagnostics and Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Brain Tumor Diagnostics and Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Brain Tumor Diagnostics and Therapeutics Market Size Markets, 2022 & 2029
4.1.2 Surgery
4.1.3 Radiation Therapy
4.1.4 Targeted Therapy
4.1.5 Chemotherapy
4.1.6 Others
4.2 By Type – Global Brain Tumor Diagnostics and Therapeutics Revenue & Forecasts
4.2.1 By Type – Global Brain Tumor Diagnostics and Therapeutics Revenue, 2018-2023
4.2.2 By Type – Global Brain Tumor Diagnostics and Therapeutics Revenue, 2024-2029
4.2.3 By Type – Global Brain Tumor Diagnostics and Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Brain Tumor Diagnostics and Therapeutics Market Size, 2022 & 2029
5.1.2 Hospitals and Cancer Center
5.1.3 Oncology Treatment Centers
5.1.4 Others
5.2 By Application – Global Brain Tumor Diagnostics and Therapeutics Revenue & Forecasts
5.2.1 By Application – Global Brain Tumor Diagnostics and Therapeutics Revenue, 2018-2023
5.2.2 By Application – Global Brain Tumor Diagnostics and Therapeutics Revenue, 2024-2029
5.2.3 By Application – Global Brain Tumor Diagnostics and Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Brain Tumor Diagnostics and Therapeutics Market Size, 2022 & 2029
6.2 By Region – Global Brain Tumor Diagnostics and Therapeutics Revenue & Forecasts
6.2.1 By Region – Global Brain Tumor Diagnostics and Therapeutics Revenue, 2018-2023
6.2.2 By Region – Global Brain Tumor Diagnostics and Therapeutics Revenue, 2024-2029
6.2.3 By Region – Global Brain Tumor Diagnostics and Therapeutics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Brain Tumor Diagnostics and Therapeutics Revenue, 2018-2029
6.3.2 US Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.3.3 Canada Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.3.4 Mexico Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Brain Tumor Diagnostics and Therapeutics Revenue, 2018-2029
6.4.2 Germany Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.4.3 France Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.4.4 U.K. Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.4.5 Italy Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.4.6 Russia Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.4.7 Nordic Countries Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.4.8 Benelux Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Brain Tumor Diagnostics and Therapeutics Revenue, 2018-2029
6.5.2 China Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.5.3 Japan Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.5.4 South Korea Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.5.5 Southeast Asia Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.5.6 India Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Brain Tumor Diagnostics and Therapeutics Revenue, 2018-2029
6.6.2 Brazil Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.6.3 Argentina Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Brain Tumor Diagnostics and Therapeutics Revenue, 2018-2029
6.7.2 Turkey Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.7.3 Israel Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.7.4 Saudi Arabia Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
6.7.5 UAE Brain Tumor Diagnostics and Therapeutics Market Size, 2018-2029
7 Brain Tumor Diagnostics and Therapeutics Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Brain Tumor Diagnostics and Therapeutics Major Product Offerings
7.1.4 Pfizer Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Brain Tumor Diagnostics and Therapeutics Major Product Offerings
7.2.4 Novartis Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Brain Tumor Diagnostics and Therapeutics Major Product Offerings
7.3.4 Roche Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Roche Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Brain Tumor Diagnostics and Therapeutics Major Product Offerings
7.4.4 Merck Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Merck Key News & Latest Developments
7.5 Curtana Pharmaceuticals
7.5.1 Curtana Pharmaceuticals Company Summary
7.5.2 Curtana Pharmaceuticals Business Overview
7.5.3 Curtana Pharmaceuticals Brain Tumor Diagnostics and Therapeutics Major Product Offerings
7.5.4 Curtana Pharmaceuticals Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Curtana Pharmaceuticals Key News & Latest Developments
7.6 GE Healthcare
7.6.1 GE Healthcare Company Summary
7.6.2 GE Healthcare Business Overview
7.6.3 GE Healthcare Brain Tumor Diagnostics and Therapeutics Major Product Offerings
7.6.4 GE Healthcare Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.6.5 GE Healthcare Key News & Latest Developments
7.7 Hitachi Medical
7.7.1 Hitachi Medical Company Summary
7.7.2 Hitachi Medical Business Overview
7.7.3 Hitachi Medical Brain Tumor Diagnostics and Therapeutics Major Product Offerings
7.7.4 Hitachi Medical Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Hitachi Medical Key News & Latest Developments
7.8 Philips Healthcare
7.8.1 Philips Healthcare Company Summary
7.8.2 Philips Healthcare Business Overview
7.8.3 Philips Healthcare Brain Tumor Diagnostics and Therapeutics Major Product Offerings
7.8.4 Philips Healthcare Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Philips Healthcare Key News & Latest Developments
7.9 Novocure
7.9.1 Novocure Company Summary
7.9.2 Novocure Business Overview
7.9.3 Novocure Brain Tumor Diagnostics and Therapeutics Major Product Offerings
7.9.4 Novocure Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.9.5 Novocure Key News & Latest Developments
7.10 AbbVie
7.10.1 AbbVie Company Summary
7.10.2 AbbVie Business Overview
7.10.3 AbbVie Brain Tumor Diagnostics and Therapeutics Major Product Offerings
7.10.4 AbbVie Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.10.5 AbbVie Key News & Latest Developments
7.11 Daiichi Sankyo
7.11.1 Daiichi Sankyo Company Summary
7.11.2 Daiichi Sankyo Business Overview
7.11.3 Daiichi Sankyo Brain Tumor Diagnostics and Therapeutics Major Product Offerings
7.11.4 Daiichi Sankyo Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.11.5 Daiichi Sankyo Key News & Latest Developments
7.12 Genetech
7.12.1 Genetech Company Summary
7.12.2 Genetech Business Overview
7.12.3 Genetech Brain Tumor Diagnostics and Therapeutics Major Product Offerings
7.12.4 Genetech Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.12.5 Genetech Key News & Latest Developments
7.13 Carthera
7.13.1 Carthera Company Summary
7.13.2 Carthera Business Overview
7.13.3 Carthera Brain Tumor Diagnostics and Therapeutics Major Product Offerings
7.13.4 Carthera Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.13.5 Carthera Key News & Latest Developments
7.14 EMulate Therapeutics
7.14.1 EMulate Therapeutics Company Summary
7.14.2 EMulate Therapeutics Business Overview
7.14.3 EMulate Therapeutics Brain Tumor Diagnostics and Therapeutics Major Product Offerings
7.14.4 EMulate Therapeutics Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2018-2023)
7.14.5 EMulate Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Brain Tumor Diagnostics and Therapeutics Market Opportunities & Trends in Global Market
Table 2. Brain Tumor Diagnostics and Therapeutics Market Drivers in Global Market
Table 3. Brain Tumor Diagnostics and Therapeutics Market Restraints in Global Market
Table 4. Key Players of Brain Tumor Diagnostics and Therapeutics in Global Market
Table 5. Top Brain Tumor Diagnostics and Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Brain Tumor Diagnostics and Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Brain Tumor Diagnostics and Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Brain Tumor Diagnostics and Therapeutics Product Type
Table 9. List of Global Tier 1 Brain Tumor Diagnostics and Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Brain Tumor Diagnostics and Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Brain Tumor Diagnostics and Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Brain Tumor Diagnostics and Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Brain Tumor Diagnostics and Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Brain Tumor Diagnostics and Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Brain Tumor Diagnostics and Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Brain Tumor Diagnostics and Therapeutics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer Brain Tumor Diagnostics and Therapeutics Product Offerings
Table 32. Pfizer Brain Tumor Diagnostics and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis Brain Tumor Diagnostics and Therapeutics Product Offerings
Table 36. Novartis Brain Tumor Diagnostics and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis Key News & Latest Developments
Table 38. Roche Company Summary
Table 39. Roche Brain Tumor Diagnostics and Therapeutics Product Offerings
Table 40. Roche Brain Tumor Diagnostics and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Roche Key News & Latest Developments
Table 42. Merck Company Summary
Table 43. Merck Brain Tumor Diagnostics and Therapeutics Product Offerings
Table 44. Merck Brain Tumor Diagnostics and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Merck Key News & Latest Developments
Table 46. Curtana Pharmaceuticals Company Summary
Table 47. Curtana Pharmaceuticals Brain Tumor Diagnostics and Therapeutics Product Offerings
Table 48. Curtana Pharmaceuticals Brain Tumor Diagnostics and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Curtana Pharmaceuticals Key News & Latest Developments
Table 50. GE Healthcare Company Summary
Table 51. GE Healthcare Brain Tumor Diagnostics and Therapeutics Product Offerings
Table 52. GE Healthcare Brain Tumor Diagnostics and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. GE Healthcare Key News & Latest Developments
Table 54. Hitachi Medical Company Summary
Table 55. Hitachi Medical Brain Tumor Diagnostics and Therapeutics Product Offerings
Table 56. Hitachi Medical Brain Tumor Diagnostics and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Hitachi Medical Key News & Latest Developments
Table 58. Philips Healthcare Company Summary
Table 59. Philips Healthcare Brain Tumor Diagnostics and Therapeutics Product Offerings
Table 60. Philips Healthcare Brain Tumor Diagnostics and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. Philips Healthcare Key News & Latest Developments
Table 62. Novocure Company Summary
Table 63. Novocure Brain Tumor Diagnostics and Therapeutics Product Offerings
Table 64. Novocure Brain Tumor Diagnostics and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 65. Novocure Key News & Latest Developments
Table 66. AbbVie Company Summary
Table 67. AbbVie Brain Tumor Diagnostics and Therapeutics Product Offerings
Table 68. AbbVie Brain Tumor Diagnostics and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 69. AbbVie Key News & Latest Developments
Table 70. Daiichi Sankyo Company Summary
Table 71. Daiichi Sankyo Brain Tumor Diagnostics and Therapeutics Product Offerings
Table 72. Daiichi Sankyo Brain Tumor Diagnostics and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 73. Daiichi Sankyo Key News & Latest Developments
Table 74. Genetech Company Summary
Table 75. Genetech Brain Tumor Diagnostics and Therapeutics Product Offerings
Table 76. Genetech Brain Tumor Diagnostics and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 77. Genetech Key News & Latest Developments
Table 78. Carthera Company Summary
Table 79. Carthera Brain Tumor Diagnostics and Therapeutics Product Offerings
Table 80. Carthera Brain Tumor Diagnostics and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 81. Carthera Key News & Latest Developments
Table 82. EMulate Therapeutics Company Summary
Table 83. EMulate Therapeutics Brain Tumor Diagnostics and Therapeutics Product Offerings
Table 84. EMulate Therapeutics Brain Tumor Diagnostics and Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 85. EMulate Therapeutics Key News & Latest Developments
List of Figures
Figure 1. Brain Tumor Diagnostics and Therapeutics Segment by Type in 2022
Figure 2. Brain Tumor Diagnostics and Therapeutics Segment by Application in 2022
Figure 3. Global Brain Tumor Diagnostics and Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Brain Tumor Diagnostics and Therapeutics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Brain Tumor Diagnostics and Therapeutics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Brain Tumor Diagnostics and Therapeutics Revenue in 2022
Figure 8. By Type - Global Brain Tumor Diagnostics and Therapeutics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Brain Tumor Diagnostics and Therapeutics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Brain Tumor Diagnostics and Therapeutics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Brain Tumor Diagnostics and Therapeutics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Brain Tumor Diagnostics and Therapeutics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Brain Tumor Diagnostics and Therapeutics Revenue Market Share, 2018-2029
Figure 16. US Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Brain Tumor Diagnostics and Therapeutics Revenue Market Share, 2018-2029
Figure 20. Germany Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 21. France Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Brain Tumor Diagnostics and Therapeutics Revenue Market Share, 2018-2029
Figure 28. China Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 32. India Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Brain Tumor Diagnostics and Therapeutics Revenue Market Share, 2018-2029
Figure 34. Brazil Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Brain Tumor Diagnostics and Therapeutics Revenue Market Share, 2018-2029
Figure 37. Turkey Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Brain Tumor Diagnostics and Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Brain Tumor Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis Brain Tumor Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Roche Brain Tumor Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck Brain Tumor Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Curtana Pharmaceuticals Brain Tumor Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. GE Healthcare Brain Tumor Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Hitachi Medical Brain Tumor Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Philips Healthcare Brain Tumor Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Novocure Brain Tumor Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. AbbVie Brain Tumor Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Daiichi Sankyo Brain Tumor Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Genetech Brain Tumor Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Carthera Brain Tumor Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. EMulate Therapeutics Brain Tumor Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 脳腫瘍診断&治療の世界市場見通し2023年-2029年(Brain Tumor Diagnostics and Therapeutics Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

脳腫瘍診断&治療の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp